Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials

Hyun-Chul Shim
{"title":"Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials","authors":"Hyun-Chul Shim","doi":"10.1177/11769343221103887","DOIUrl":null,"url":null,"abstract":"CRISPR-Cas systems are an adaptive immunity that protects prokaryotes against foreign genetic elements. Genetic templates acquired during past infection events enable DNA-interacting enzymes to recognize foreign DNA for destruction. Due to the programmability and specificity of these genetic templates, CRISPR-Cas systems are potential alternative antibiotics that can be engineered to self-target antimicrobial resistance genes on the chromosome or plasmid. However, several fundamental questions remain to repurpose these tools against drug-resistant bacteria. For endogenous CRISPR-Cas self-targeting, antimicrobial resistance genes and functional CRISPR-Cas systems have to co-occur in the target cell. Furthermore, these tools have to outplay DNA repair pathways that respond to the nuclease activities of Cas proteins, even for exogenous CRISPR-Cas delivery. Here, we conduct a comprehensive survey of CRISPR-Cas genomes. First, we address the co-occurrence of CRISPR-Cas systems and antimicrobial resistance genes in the CRISPR-Cas genomes. We show that the average number of these genes varies greatly by the CRISPR-Cas type, and some CRISPR-Cas types (IE and IIIA) have over 20 genes per genome. Next, we investigate the DNA repair pathways of these CRISPR-Cas genomes, revealing that the diversity and frequency of these pathways differ by the CRISPR-Cas type. The interplay between CRISPR-Cas systems and DNA repair pathways is essential for the acquisition of new spacers in CRISPR arrays. We conduct simulation studies to demonstrate that the efficiency of these DNA repair pathways may be inferred from the time-series patterns in the RNA structure of CRISPR repeats. This bioinformatic survey of CRISPR-Cas genomes elucidates the necessity to consider multifaceted interactions between different genes and systems, to design effective CRISPR-based antimicrobials that can specifically target drug-resistant bacteria in natural microbial communities.","PeriodicalId":136690,"journal":{"name":"Evolutionary Bioinformatics Online","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evolutionary Bioinformatics Online","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11769343221103887","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

CRISPR-Cas systems are an adaptive immunity that protects prokaryotes against foreign genetic elements. Genetic templates acquired during past infection events enable DNA-interacting enzymes to recognize foreign DNA for destruction. Due to the programmability and specificity of these genetic templates, CRISPR-Cas systems are potential alternative antibiotics that can be engineered to self-target antimicrobial resistance genes on the chromosome or plasmid. However, several fundamental questions remain to repurpose these tools against drug-resistant bacteria. For endogenous CRISPR-Cas self-targeting, antimicrobial resistance genes and functional CRISPR-Cas systems have to co-occur in the target cell. Furthermore, these tools have to outplay DNA repair pathways that respond to the nuclease activities of Cas proteins, even for exogenous CRISPR-Cas delivery. Here, we conduct a comprehensive survey of CRISPR-Cas genomes. First, we address the co-occurrence of CRISPR-Cas systems and antimicrobial resistance genes in the CRISPR-Cas genomes. We show that the average number of these genes varies greatly by the CRISPR-Cas type, and some CRISPR-Cas types (IE and IIIA) have over 20 genes per genome. Next, we investigate the DNA repair pathways of these CRISPR-Cas genomes, revealing that the diversity and frequency of these pathways differ by the CRISPR-Cas type. The interplay between CRISPR-Cas systems and DNA repair pathways is essential for the acquisition of new spacers in CRISPR arrays. We conduct simulation studies to demonstrate that the efficiency of these DNA repair pathways may be inferred from the time-series patterns in the RNA structure of CRISPR repeats. This bioinformatic survey of CRISPR-Cas genomes elucidates the necessity to consider multifaceted interactions between different genes and systems, to design effective CRISPR-based antimicrobials that can specifically target drug-resistant bacteria in natural microbial communities.
研究基于crispr的抗菌剂CRISPR-Cas基因组的基因组背景
CRISPR-Cas系统是一种保护原核生物免受外来遗传因子侵害的适应性免疫系统。在过去感染事件中获得的遗传模板使DNA相互作用酶能够识别外来DNA进行破坏。由于这些遗传模板的可编程性和特异性,CRISPR-Cas系统是潜在的替代抗生素,可以被设计成自靶向染色体或质粒上的抗菌素抗性基因。然而,要重新利用这些工具来对付耐药细菌,还有几个基本问题有待解决。对于内源性CRISPR-Cas自靶向,抗菌耐药基因和功能性CRISPR-Cas系统必须在靶细胞中共同出现。此外,这些工具必须胜过响应Cas蛋白核酸酶活性的DNA修复途径,即使是外源性CRISPR-Cas递送。在这里,我们对CRISPR-Cas基因组进行了全面的调查。首先,我们解决了CRISPR-Cas系统和CRISPR-Cas基因组中抗菌素耐药基因的共存问题。我们发现这些基因的平均数量因CRISPR-Cas类型而异,一些CRISPR-Cas类型(IE和IIIA)每个基因组有超过20个基因。接下来,我们研究了这些CRISPR-Cas基因组的DNA修复途径,揭示了这些途径的多样性和频率因CRISPR-Cas类型而异。CRISPR- cas系统和DNA修复途径之间的相互作用对于在CRISPR阵列中获得新的间隔物至关重要。我们进行了模拟研究,以证明这些DNA修复途径的效率可以从CRISPR重复序列的RNA结构的时间序列模式推断出来。这项CRISPR-Cas基因组的生物信息学调查阐明了考虑不同基因和系统之间多方面相互作用的必要性,以设计有效的基于crispr的抗菌剂,可以专门针对天然微生物群落中的耐药细菌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信